Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ozempic
Ozempic
GLP-1s set to take drug sales throne from PD-1 inhibitors in 2024
Medical Marketing and Media
Wed, 03/20/24 - 09:43 pm
GLP-1 agonist
PD-1 inhibitors
Wegovy
Ozempic
Zepbound
Mounjaro
How the Ozempic gold rush is causing ‘deeply concerning’ shortage for diabetes patients
Biopharma Reporter
Wed, 03/13/24 - 11:16 am
Ozempic
Novo Nordisk
GLP-1
diabetes
drug shortages
Novo Nordisk working with global authorities to take down fake Ozempic
Beckers Hospital Review
Mon, 03/11/24 - 05:03 pm
Novo Nordisk
drug counterfeiting
Ozempic
Novo kidney trial finds Ozempic cuts cardiac risks in diabetics
Reuters
Tue, 03/5/24 - 11:52 am
Novo Nordisk
Ozempic
clinical trials
diabetes
chronic kidney disease
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite
Motley Fool
Sun, 03/3/24 - 09:48 pm
Ozempic
Abbott Labs
Medtech
diabetes
CGMs
Americans don't think weight-loss drugs will fix the obesity epidemic
Axios
Wed, 02/28/24 - 10:44 am
obesity
weight loss
Ozempic
Wegovy
Zepbound
GLP-1 agonist
Novo Nordisk and Catalent deal: net positive or negative for industry?
Biopharma Reporter
Tue, 02/20/24 - 11:06 am
Novo Nordisk
Catalent
M&A
Wegovy
Ozempic
Weight loss drugs like Ozempic have food CEOs so 'scared' they're calling Novo Nordisk for advice
Quartz
Thu, 02/15/24 - 07:20 pm
Novo Nordisk
Lars Fruergaard Jorgensen
Ozempic
Wegovy
weight loss
Weight-loss drugs tied to benefit after hip replacement
Reuters
Mon, 02/12/24 - 10:26 am
hip replacements
GLP-1 agonist
Ozempic
Novo Nordisk
New weight-loss drugs linked to lower risk of depression: study
Axios
Fri, 02/9/24 - 11:12 am
depression
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Could Novo, Lilly become first trillion-dollar healthcare companies?
Pharma Voice
Mon, 02/5/24 - 10:30 am
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
obesity
weight loss
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
CNBC
Mon, 02/5/24 - 10:10 am
Novo Nordisk
Catalent
drug manufacturing
M&A
Wegovy
Ozempic
Novo Nordisk doubles stock of Wegovy starter doses but supply constraints persist: CEO
Fierce Pharma
Wed, 01/31/24 - 11:56 am
Novo Nordisk
Wegovey
earnings
Ozempic
Many patients keep weight off after stopping anti-obesity meds: study
Axios
Wed, 01/24/24 - 10:44 am
obesity
Novo Nordisk
Ozempic
Wegovy
Saxenda
Victoza
Drugmakers explore muscle loss prevention when taking weight loss drugs
Beckers Hospital Review
Tue, 01/23/24 - 11:06 am
weight loss
muscle
Ozempic
Wegovy
Eli Lilly
Regeneron
United States of Ozempic: Where anti-obesity drugs are taking off
Axios
Fri, 01/19/24 - 09:31 am
Ozempic
Zepbound
Wegovy
Novo Nordisk
Eli Lilly
obesity
United States
List Price Of Ozempic And Other Drugs Reportedly Rise: Here’s What That Means For Consumers
Forbes
Thu, 01/18/24 - 04:53 pm
drug pricing
Ozempic
Mounjaro
Researchers probe new uses of popular weight loss, diabetes drugs
Beckers Hospital Review
Tue, 01/16/24 - 09:08 am
GLP-1 agonist
Ozempic
Mounjaro
Wegovy
Novo Nordisk
Eli Lilly
Ozempic not tied to pancreatic cancer risk, study suggests
Beckers Hospital Review
Tue, 01/9/24 - 10:04 pm
Ozempic
Trulicity
type 2 diabetes
Novo Nordisk
GLP-1 agonist
pancreatic cancer
Wegovy, Ozempic not linked to increase in suicidal thoughts, US study finds
Reuters
Fri, 01/5/24 - 09:55 am
Novo Nordisk
Wegovy
Ozempic
side effects
Pages
1
2
3
4
5
6
next ›
last »